Piramal Pharma Board to Consider Q2 Results on 27th Oct'26
Piramal Pharma Ltd 路 Intimation 路 27 Oct 2026, 5:30 am
Piramal Pharma Board to Consider Q2 Results on 27th Oct'26 Piramal Pharma Limited announced that its Board of Directors will meet on 27th Oct'26 to consider and approve the standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. Additionally, the trading window for dealing in company securities, which closed on 1st Oct'26, will remain shut until 29th Oct'26 (both days inclusive) in compliance with SEBI listing regulations.
Original exchange filing (PDF)
More announcements from Piramal Pharma Ltd
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for HDFC Mutual Fund 路 31 Oct 2026
- Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI LODR Regulations, 2015 路 30 Oct 2026
- Please find enclosed details of Earning call Transcript held on 28th October 2026. 路 30 Oct 2026
- Please find enclosed intimation of audio recordings of the conference call held today 28th October, 2026. 路 28 Oct 2026
- Please find enclosed Investor presentation for quarter ended 30 September, 2026 路 28 Oct 2026
- Please find enclosed Press release for quarter ended 30 September, 2026 路 28 Oct 2026
- Piramal Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 28 Oct 2026
- Please find enclosed unaudited financial results for Q2 FY 27 路 28 Oct 2026
